|
Note: Print this page for easy reference
|
Colorectal Cancer: New Frontiers in Therapy and Support |
|
NOTE:
The broadcast schedule for this program is complete. If you
have questions regarding your educational credit: Contact
the sponsor at 718-920-6674.
Financial support for this activity is provided by an unrestricted
educational grant from Sanofi-Synthelabo Inc., a member of the sanofi-aventis
Group. Course Director Lakshmi Rajdev, MD, Assistant Professor, Montefiore Medical Center -- Weiler Division,
Division of Oncology, Bronx, NY Nursing Coordinator Mary McLoughlin, RN, MSN, CEN Faculty Moderator: Edward Chu, MD, Professor of Medicine and Pharmacology, Yale University
School of Medicine, New Haven, CT Alan P. Venook, MD, Professor, Clinical Medicine, University of California San
Francisco, San Francisco, CA Richard M. Goldberg, MD, Professor of Medicine, Director, Division of
Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel
Hill, NC Bruce Minsky, MD, Professor of Radiation Oncology, Weill Medical College of Cornell
University, Vice Chairman, Department of Radiation Oncology, Memorial
Sloan-Kettering Cancer Center, Department of Radiation Oncology, New York, NY Al Benson III, MD, Professor of Medicine, Division of Hematology/Oncology, Northwestern
University Feinberg School of Medicine, Associate Director for Clinical
Investigations, Robert H. Lurie Comprehensive Cancer Center of Northwestern
University, Chicago, IL Statement of Need Colorectal cancer (CRC) is the third most prevalent form of cancer,
following carcinomas of the prostate and lung in men and of the breast and
lung in women. Among nonsmoking men and women, CRC is the leading cause of
cancer death in the Learning Objectives Upon completion of this activity, the participants should be able to: Discuss the various treatment options in CRC metastatic disease;
describe the latest advances in the medical treatment of CRC targeted
therapy; discuss the rationale for adjuvant therapy; describe supportive care
procedures including quality of life issues with regard to patients
undergoing therapy for CRC. ACCREDITATION/DESIGNATION STATEMENT Albert Einstein College of Medicine is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing medical
education for physicians. Physicians:
Albert Einstein College of Medicine designates this educational
activity for a maximum of 2 Category 1 Credits toward the AMA Physician's
Recognition Award. Each physician should claim those credits that he/she
actually spent in the educational activity. This CME activity was planned and produced in accordance with the
ACCME Essentials.
This program is approved for 2 hours credit (0.2 CEUs) and is
co-sponsored with the University of Tennessee College of Pharmacy who is
approved by the American Council for Pharmacy Education as a provider of
continuing pharmaceutical education. A statement of CE credit will be mailed
to participants within 3 to 4 weeks of the conclusion of the program. ACPE
Program #064-999-04-274-L01 (Live Broadcast on December 15, 2004) and
064-999-04-274-H01 (Re-broadcasts on January 12 & 27, 2005). Live Broadcast -- December 15, 2004 To receive a statement of CEU credit, attendance must be acknowledged
at the registration desk upon arrival at the broadcast site, and the
participant must complete the activity attendance sheet and evaluation form
and either fax these to Steven Jay Feld at 718-798-2336, or mail them to: Steven Jay Feld CCME Taped Re-Broadcast -- January 12 & 27, 2005 To receive a statement of CEU credit, the participant must complete
the activity attendance sheet, evaluation form and successfully answer 70% of
the questions on the Test Sheet and then either fax these to Steven Jay Feld
at 718-798-2336, or mail them to: Steven Jay Feld CCME Nurses: Live Broadcast and Taped Rebroadcasts: To receive a statement of CE credit, the participant must complete the
activity attendance sheet, evaluation form and successfully answer correctly
70% of the questions on the Test Sheet and then either fax all of these to
Steven Jay Feld at 718-798-2336, or mail them to: Steven Jay Feld CCME FACULTY DISCLOSURE The "Faculty Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship with a pharmaceutical or equipment company which might pose a potential, apparent or real conflict of interest with regard to their contribution to the activity, and any discussions of unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. |
|
|
©Copyright VitalSigns Healthcare
TV |
|
